AZN new Head of Investor Relations Joris Silon

Summary by AI BETAClose X

AstraZeneca has appointed Joris Silon as its new Head of Investor Relations, effective March 1, 2026, succeeding Andy Barnett. Silon, who will be based in Cambridge, UK, previously served as Country President of AstraZeneca US, where he drove significant growth in the company's largest market. His extensive pharmaceutical experience spans leadership roles across Asia, Europe, and the US since joining the company in 2000. The Chief Financial Officer expressed confidence in Silon's ability to lead the Investor Relations team through the company's next growth phase and thanked Barnett for his four years of leadership.

Disclaimer*

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings